AB

Advanced Biomedical Technologies IncOOTC ABMT Stock Report

Last reporting period 31 Jul, 2021

Updated —

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

ABMT Stock Analysis

AB

Uncovered

Advanced Biomedical Technologies Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-51/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

70.9 B

Website

Advanced BioMedical Technologies, Inc. engages in the provision of medical and pain management tools. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The firm's primary products include Polymer Osteosynthesis Devices made of a material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly(methyl methacrylate-co-N-vinylpyrrolidone) (P(MMAco-NVP)). These advanced materials are used in surgical screws, binding wires, rods and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. The firm's PA products, such as screws, binding wires, rods, suture anchors and rib-pins consist of enhanced fibers and high molecular polymers which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.

View Section: Eyestock Rating